|
 |
Deciding on treatment for Parkinson'sUnderstanding Parkinson's diseaseEarly disease The biggest question once a correct diagnosis of Parkinson's disease has been made is when to start treatment and the medication used for that treatment. Treatments can vary greatly depending on the age, condition of the patient and understanding of the disease and its treatment that the patient has. In the early stages of the disease depression and anxiety may also play a part in the debilitating symptoms and therefore will become one of the main objects of concern when deciding on initial treatment. Neuroprotective agents If Neuroprotective agents are identified then they will obviously be the first treatment which is offered to the patient and treatment will commence as soon as possible. However no agent has been known to offer 100% neuroprotection, one medication that has a mild symptomatic effect is Selegiline and this is very often used in the early stages of Parkinson's disease. Starting symptomatic therapy The decision of when to actually begin treatment is one that is made between the patient and their Doctor and several factors are taken into account, these are the degree of impairment, the effects the symptoms are having on the patient's employment and the patient's attitude towards taking medication. If the patient fully understands the limitations and benefits they can reap from the medication then their preference will count for a lot in the decision making process. The patients understanding makes a huge difference because many times over the treatment period they will have to be re-evaluated and have their medication adjusted with the progression of the disease or the patients response to the therapy. It is therefore in the best interests of both parties that they develop a partnership from the very beginning. The initial treatment options The patient's age and condition will make a huge difference to the choice of initial treatment; the drug Levodopa is usually the first choice of medication for those sufferers who are elderly. A dopamine agonist will usually be chosen for the younger patient as younger people are more tolerant of the side effects the drug can produce. In the younger patients delaying of the onset of motor skills problems is also a huge concern with Selegiline, amantadine or anticholinergic medication being excellent initial treatments for mild symptoms of the disease, providing of course that the side effects most of these medications produce can be tolerated. If depression and anxiety are one of the concerns then this will usually be treated with medications such as anti-depressants, it is thought that over 50% of all those suffering with Parkinson's disease will also suffer from depression and anxiety. |
Deciding on treatment for Parkinson'sHomeWhat is Parkinson's disease?Alternative medicine & Parkinson'sCare for the Parkinson's care giverCoping & living with Parkinson'sDeep brain stimulation for Parkinson'sDepression & Parkinson'sDiagnosis of Parkinson'sExercise therapy for people with Parkinson'sParkinson's disease faqParkinson's disease glossaryMaintaining your health with Parkinson's diseasePain & Parkinson's diseaseParkinson's disease & parenthoodParkinson's disease & allergiesParkinson's, speech therapy & self helpPhysical & occupational therapy for Parkinson'sSelf help for people with Parkinson'sSurgery options for Parkinson's diseaseMental disturbances associated with Parkinson'sParkinson's disease risk factorsParkinson's disease symptomsParkinson's disease treatment optionsUnderstanding Parkinson's diseaseWhat does having Parkinson's disease mean?
Alzheimer's DiseaseBleach in Teabags - Health RisksFolliculitis picturesPictures of staph infectionDementia Disease |
Contact Us© Copyright Pdring.com - Parkinson's disease guide - All rights reserved. |
